Skip to main navigation Skip to search Skip to main content

Physical activity and capacity at initiation of antiretroviral treatment in HIV patients in Ethiopia

  • M. F. Olsen*
  • , Pernille Kæstel
  • , Markos Tesfaye
  • , Alemseged Abdissa
  • , Daniel Yilma
  • , Tsinuel Girma
  • , C. Molgaard
  • , D. Faurholt-Jepsen
  • , D. L. Christensen
  • , Soren Brage
  • , A. B. Andersen
  • , H Friis
  • *Corresponding author for this work
    25 Citations (Scopus)

    Abstract

    We described levels of habitual physical activity and physical capacity in HIV patients initiating antiretroviral treatment in Ethiopia and assessed the role of HIV and nutritional indicators on these outcomes. Physical activity energy expenditure (PAEE) and activity levels were measured with combined heart rate and movement sensors. Physical capacity was assessed by grip strength, sleeping heart rate and heart rate economy. Grip strength data was also available from a sex- and age-matched HIV-negative reference group. Median PAEE was 27·9 (interquartile range 17·4-39·8) kJ/kg per day and mean±s.d. grip strength was 23·6 ± 6·7 kg. Advanced HIV disease predicted reduced levels of both physical activity and capacity; e.g. each unit viral load [log(1+copies/ml)] was associated with -15% PAEE (P < 0·001) and -1·0 kg grip strength (P < 0·001). Grip strength was 4·2 kg lower in patients compared to HIV-negative individuals (P < 0·001). Low body mass index (BMI) predicted poor physical activity and capacity independently of HIV status, e.g. BMI <16 was associated with -42% PAEE (P < 0·001) and -6·8 kg grip strength (P < 0·001) compared to BMI

    Original languageEnglish
    JournalEpidemiology and Infection
    Volume143
    Issue number5
    Pages (from-to)1048-1058
    Number of pages11
    ISSN0950-2688
    DOIs
    Publication statusPublished - 11 Apr 2015

    Keywords

    • Epidemiology
    • HIV/AIDS
    • infectious disease epidemiology
    • public health

    Fingerprint

    Dive into the research topics of 'Physical activity and capacity at initiation of antiretroviral treatment in HIV patients in Ethiopia'. Together they form a unique fingerprint.

    Cite this